INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

AMRXAmneal Pharmaceuticals, Inc.

CIK 0001723128

EDGAR filingsOpen in network
Disclosed transactions1
Buys / sells0 / 0
Max Insider Score20
Connections5with evidence

AMRX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
BK
Buchi J KevinDirector
AMRXAmneal Pharmaceuticals, Inc.
Gift
G—
20.4K sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Connected organizationevidence
    AMNEAL PHARMACEUTICALS INC. PACFEC Form 1 connected organization: AMNEAL PHARMACEUTICALS INC. (exact legal-name match) · Nov 4, 2026
  • ← Insider ofevidence
    Buchi J KevinDirector · Sep 21, 2026
  • ← Lobbied forevidence
    OGRLDA Q2 2026 second quarter · MAN · Aug 26, 2026
  • ← Lobbied forevidence
    TARPLIN, DOWNS & YOUNG, LLCLDA Q2 2026 second quarter · Health issues, Budget/appropriations · Aug 26, 2026

    • Lobbying

    $380K reported · de-duplicated
    2026 Q2 $190K in-house2026 Q1 $190K in-house
    • OGR$20K2026 Q1 · posted Aug 26, 2026 · MAN
    • OGR$20K2026 Q2 · posted Aug 26, 2026 · MAN
    • TARPLIN, DOWNS & YOUNG, LLC$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Budget/appropriations
    • In-house report$190K2026 Q1 · posted Aug 26, 2026 · Health issues
    • In-house report$190K2026 Q2 · posted Aug 26, 2026 · Health issues
    • TARPLIN, DOWNS & YOUNG, LLC$60K2026 Q2 · posted Aug 26, 2026 · Health issues, Budget/appropriations

    Connected PAC contributions

    FEC · direct to members
    • Roger MarshallR$7,000AMNEAL PHARMACEUTICALS INC. PAC
    • Brian SchatzD$5,000AMNEAL PHARMACEUTICALS INC. PAC
    • Ben ClineR$4,000AMNEAL PHARMACEUTICALS INC. PAC
    • Diana DeGetteD$3,500AMNEAL PHARMACEUTICALS INC. PAC
    • Lori TrahanD$3,000AMNEAL PHARMACEUTICALS INC. PAC
    Dan CrenshawR
    $2,500
    AMNEAL PHARMACEUTICALS INC. PAC
  • Jake AuchinclossD$2,000AMNEAL PHARMACEUTICALS INC. PAC
  • Andrew R. GarbarinoR$1,000AMNEAL PHARMACEUTICALS INC. PAC
  • Suzan K. DelBeneD$1,000AMNEAL PHARMACEUTICALS INC. PAC
  • Kim SchrierD$1,000AMNEAL PHARMACEUTICALS INC. PAC
  • Earl L. "Buddy" CarterR$1,000AMNEAL PHARMACEUTICALS INC. PAC
  • Brian K. FitzpatrickR$0AMNEAL PHARMACEUTICALS INC. PAC
    • Source error

    Price history for AMRX is unavailable.

    An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.